Expression of EpCAM Increases in the Hepatitis B Related and the Treatment-Resistant Hepatocellular Carcinoma

Table 3

Clinical profiles of surgery alone patients and patients who received prior treatment.

	Non prior treatment	Prior treatment (TACE or HAIC)
Number	58	13
Age	63.9±10.3	62.6±9.9	𝑝=0.7322
Sex (male/female)	14/4	15/8	𝑝=0.2369
Etiology (HBV/HCV/NBNC)	18/23/17	3/7/3	𝑝=0.6470
Tumor size (mm)	52.7±40.8	28.6±18.9	𝑝=0.0118
ALT (IU/L)	52.5±42.7	35.8±17.9	𝑝=0.3683
γGTP (IU/L)	95.6±104.7	58.5±29.4	𝑝=0.4438
Plt (×10^3/𝜇L)	176.3±61.6	172.8±112.2	𝑝=0.2553
Child-Pugh classification (𝐴/𝐵)	58/0	11/2	𝑝=0.024
AFP (ng/mL)	1684.1±6325.6	2529.1±7414.3	𝑝=0.6936

Data expressed as mean ± SD. Sex, etiology, and Child-Pugh were classification analyzed by 𝜒² test. Other data were analyzed by Kruskal-Wallis test.